Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Modeling Cystic Fibrosis (CF) airway disease and therapies in patient derived tissues
FY 2016-17
Summary
Cystic Fibrosis (CF) is caused by mutations in the Cystic Fibrosis Conductance Transmembrane Regulator ( CFTR ) gene. CFTR is a protein that is expressed at the cell surface and is responsible for maintaining hydration of respiratory and intestinal tracts. Mutation in the CFTR gene will lead to disruptions in forming proper barriers in between cells. Improper barriers in the airway and intestines would expose the body to environmental bacteria and toxins. However, the exact interactions between the barrier proteins and CFTR is not well characterized. Our model will include using human airway cells expressing normal CFTR or one of the two common CFTR mutantions. These CFTR mutations will be edited into the genome of airway cells and grown into 2-dimensional (2D) cell monolayers to directly monitor CFTR function. In parallel with the conventional methods of culturing cell monolayers, airway cells will also be cultured into 3-dimensional (3D) spheres to investigate the fluid secretory abilities of CFTR protein. We plan to use two major CFTR mutants, one of which is present but not functional at the cell surface and another that is prematurely degraded, to help understand whether the presence of CFTR at the cell surface is needed or is it the proper function of CFTR that is required for barrier formation in between cells. Future studies will focus on using airway cells derived from CF patients cultured into 2D cell monolayers and 3D spheres, which better mimic the structure of the airways, to understand the disease at a more personalized level. Determining how CFTR is interacting with other proteins will provide more knowledge in regards to developing future CF therapies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367377
Name
Xia Sunny
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Modeling Cystic Fibrosis (CF) airway disease and therapies in patient derived tissues
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
3d Organoids; Airway Disease Phenotype; Cftr-Mediated Fluid Secretion; Channel Function; Cystic Fibrosis; Epithelium Health; Modifier Genes; Patient-Derived Primary Cultures
Abstract
Cystic Fibrosis (CF) is caused by mutations in the Cystic Fibrosis Conductance Transmembrane Regulator ( CFTR ) gene. CFTR is a protein that is expressed at the cell surface and is responsible for maintaining hydration of respiratory and intestinal tracts. Mutation in the CFTR gene will lead to disruptions in forming proper barriers in between cells. Improper barriers in the airway and intestines would expose the body to environmental bacteria and toxins. However, the exact interactions between the barrier proteins and CFTR is not well characterized. Our model will include using human airway cells expressing normal CFTR or one of the two common CFTR mutantions. These CFTR mutations will be edited into the genome of airway cells and grown into 2-dimensional (2D) cell monolayers to directly monitor CFTR function. In parallel with the conventional methods of culturing cell monolayers, airway cells will also be cultured into 3-dimensional (3D) spheres to investigate the fluid secretory abilities of CFTR protein. We plan to use two major CFTR mutants, one of which is present but not functional at the cell surface and another that is prematurely degraded, to help understand whether the presence of CFTR at the cell surface is needed or is it the proper function of CFTR that is required for barrier formation in between cells. Future studies will focus on using airway cells derived from CF patients cultured into 2D cell monolayers and 3D spheres, which better mimic the structure of the airways, to understand the disease at a more personalized level. Determining how CFTR is interacting with other proteins will provide more knowledge in regards to developing future CF therapies.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Xia, Sunny
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~